AstraZeneca advances weight-loss pill to take aim at obesity leaders

Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×